Cargando…

Effects of Anti-Cytokine Antibodies on Gut Barrier Function

Anti-cytokine antibodies are used in treating chronic inflammatory diseases and autoimmune diseases such as inflammatory bowel disease and rheumatic diseases. Patients with these diseases often have a compromised gut barrier function, suggesting that anti-cytokine antibodies may contribute to the re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fang, Lee, Seul A., Riordan, Stephen M., Zhang, Li, Zhu, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875247/ https://www.ncbi.nlm.nih.gov/pubmed/31780866 http://dx.doi.org/10.1155/2019/7028253

Ejemplares similares

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
por: Liu, Fang, et al.
Publicado: (2020)

Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function
por: Lee, Jae-Young, et al.
Publicado: (2023)

Th17 Cytokines and the Gut Mucosal Barrier
por: Blaschitz, Christoph, et al.
Publicado: (2010)

Beneficial effects of ulinastatin on gut barrier function in sepsis
por: Jiang, Longyuan, et al.
Publicado: (2013)

Cytokines and the Skin Barrier
por: Hänel, Kai H., et al.
Publicado: (2013)

Role of gut microbiota in functional constipation
por: Zhang, Shengsheng, et al.
Publicado: (2021)

Th17 Cytokines and Barrier Functions
por: Wang, Guansong, et al.
Publicado: (2016)

Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody
por: Isozaki, Takeo, et al.
Publicado: (2020)

Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
por: Lee, Seul A., et al.
Publicado: (2019)

Global epidemiology of campylobacteriosis and the impact of COVID-19
por: Liu, Fang, et al.
Publicado: (2022)

The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation
por: Hiippala, Kaisa, et al.
Publicado: (2018)

Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms
por: Zhang, Li, et al.
Publicado: (2022)

Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
por: Fang, Jian, et al.
Publicado: (2021)

The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier
por: Tang, Wei, et al.
Publicado: (2020)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers
por: Carloni, Sara, et al.
Publicado: (2022)

Effects of the Gut Microbiota and Barrier Function on Melatonin Efficacy in Alleviating Liver Injury
por: Zhang, Hao, et al.
Publicado: (2022)

Homeostasis of the gut barrier and potential biomarkers
por: Wells, Jerry M., et al.
Publicado: (2017)

Intrathecal cytokine profile in neuropathy with anti‐neurofascin 155 antibody
por: Ogata, Hidenori, et al.
Publicado: (2019)

The gut microbiota is important for the maintenance of blood–cerebrospinal fluid barrier integrity
por: Knox, Emily G., et al.
Publicado: (2022)

Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver
por: Guo, Weina, et al.
Publicado: (2021)

Innate Lymphoid Cells: Regulators of Gut Barrier Function and Immune Homeostasis
por: Fan, Hui, et al.
Publicado: (2019)

Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Dai, Xin, et al.
Publicado: (2015)

Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors
por: Gwak, Min-Gyu, et al.
Publicado: (2021)

Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
por: Usuda, Haruki, et al.
Publicado: (2021)

Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors
por: Liao, Shaohua, et al.
Publicado: (2021)

Anti-CD28 Antibody-Initiated Cytokine Storm in Canines
por: Rosinski, Steven L., et al.
Publicado: (2015)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Gut and obesity/metabolic disease: Focus on microbiota metabolites
por: Lin, Ke, et al.
Publicado: (2022)

Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease
por: Maccioni, Luca, et al.
Publicado: (2021)

Overview of the Importance of Biotics in Gut Barrier Integrity
por: Kocot, Aleksandra Maria, et al.
Publicado: (2022)

Enteroendocrine System and Gut Barrier in Metabolic Disorders
por: Osinski, Céline, et al.
Publicado: (2022)

Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
por: Scheau, Cristian, et al.
Publicado: (2021)

Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier
por: Mohapatra, Gayatree, et al.
Publicado: (2021)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
por: Parsons, Matthew S., et al.
Publicado: (2018)

Cytokines Involved in the Pathogenesis of SSc and Problems in the Development of Anti-Cytokine Therapy
por: Shima, Yoshihito
Publicado: (2021)

Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
por: Essogmo, Freddy Elad, et al.
Publicado: (2023)

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
por: Son, Mijeong, et al.
Publicado: (2022)

Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
por: Kurilenko, Natalia, et al.
Publicado: (2021)

The Role of the Gut Barrier Function in Health and Disease
por: Assimakopoulos, Stelios F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_570rb95q2h2urptd76i3ccbug5